AC Immune SA (ACIU)
3.00
+0.16
(+5.63%)
USD |
NASDAQ |
Nov 01, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
AC Immune Market Cap: 296.82M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 296.82M |
| October 31, 2024 | 280.99M |
| October 30, 2024 | 293.85M |
| October 29, 2024 | 297.81M |
| October 28, 2024 | 296.82M |
| October 25, 2024 | 301.77M |
| October 24, 2024 | 296.82M |
| October 23, 2024 | 300.78M |
| October 22, 2024 | 307.70M |
| October 21, 2024 | 303.75M |
| October 18, 2024 | 309.68M |
| October 17, 2024 | 317.60M |
| October 16, 2024 | 315.62M |
| October 15, 2024 | 316.61M |
| October 14, 2024 | 315.62M |
| October 11, 2024 | 328.48M |
| October 10, 2024 | 330.46M |
| October 09, 2024 | 335.41M |
| October 08, 2024 | 327.49M |
| October 07, 2024 | 336.40M |
| October 04, 2024 | 334.42M |
| October 03, 2024 | 335.41M |
| October 02, 2024 | 344.31M |
| October 01, 2024 | 371.03M |
| September 30, 2024 | 373.99M |
| Date | Value |
|---|---|
| September 27, 2024 | 371.03M |
| September 26, 2024 | 366.08M |
| September 25, 2024 | 365.09M |
| September 24, 2024 | 368.06M |
| September 23, 2024 | 362.12M |
| September 20, 2024 | 365.09M |
| September 19, 2024 | 365.09M |
| September 18, 2024 | 359.15M |
| September 17, 2024 | 342.33M |
| September 16, 2024 | 323.53M |
| September 13, 2024 | 314.63M |
| September 12, 2024 | 301.77M |
| September 11, 2024 | 302.76M |
| September 10, 2024 | 304.74M |
| September 09, 2024 | 301.77M |
| September 06, 2024 | 295.83M |
| September 05, 2024 | 307.70M |
| September 04, 2024 | 308.69M |
| September 03, 2024 | 302.76M |
| August 30, 2024 | 319.58M |
| August 29, 2024 | 319.58M |
| August 28, 2024 | 310.67M |
| August 27, 2024 | 302.76M |
| August 26, 2024 | 312.65M |
| August 23, 2024 | 304.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.47M
Minimum
Dec 22 2022
710.69M
Maximum
Jan 15 2020
372.49M
Average
357.27M
Median
Oct 07 2020
Market Cap Benchmarks
| CRISPR Therapeutics AG | 4.323B |
| Addex Therapeutics Ltd | 11.44M |
| NLS Pharmaceutics Ltd | 13.73M |
| Molecular Partners AG | 203.08M |
| MoonLake Immunotherapeutics | 2.941B |
Market Cap Related Metrics
| Price to Book Value | 2.162 |
| Price to Free Cash Flow | 5.768 |
| Price | 3.00 |
| Earnings Yield | -24.02% |